Products & Services » Diagnostics » IBD Serology

Prometheus IBD Serologoy 7. See. More. Clearly

PROMETHEUS® IBD Serology 7 helps identify IBD and differentiates between ulcerative colitis and Crohn’s disease. This test includes the proprietary and patented markers anti-CBir1, anti-OmpC and DNAse-sensitive pANCA process that helps identify patients with IBD and utilizes Smart Diagnostic Algorithm* technology to improve predictive accuracy. While most other labs only offer assay values, PROMETHEUS IBD Serology 7 provides a diagnostic prediction on every test and prognostic information that may guide treatment decisions. For references please see Product Information Brochure.

Understanding the Science behind IBD Serology 7

Prometheus diagnostic services provide important information to aid in the diagnosis and management of certain diseases and conditions. How this information is used to guide patient care is the responsibility of the physician.

*Patent pending

Reference within this site to any specific advertisement or promotion of a non-Prometheus product
does not constitute an endorsement or recommendation by Prometheus.
© 2010 Prometheus. All Rights Reserved. Mkt Doc 100 Rev. F